NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / COVID-19: Serum to start producing Sputnik V vaccine from September
    COVID-19: Serum to start producing Sputnik V vaccine from September
    1/8
    India 3 min read

    COVID-19: Serum to start producing Sputnik V vaccine from September

    By Sagar
    Jul 13, 2021
    04:19 pm
    COVID-19: Serum to start producing Sputnik V vaccine from September
    Serum Institute of India is set to start producing the Sputnik V vaccine from September.

    The Serum Institute of India (SII) will begin producing the Russian COVID-19 vaccine, Sputnik V, from September, the Russian Direct Investment Fund (RDIF) announced today. The RDIF funds and markets this vaccine across the globe. SII and the RDIF plan to produce over 300 million (30 crore) vaccine doses in India annually, they said. Here are more details on this.

    2/8

    Technology transfer has already started, RDIF says

    On July 4, the Drugs Controller General of India (DCGI) had granted test license to SII for manufacturing small batches, meant for examination and analysis, at its licensed facility in Pune. Technology transfer has already started and the SII has received cell and vector samples from the Gamaleya Center in Russia, which has developed the vaccine.

    3/8

    'Delighted to cooperate with Serum Institute of India'

    "RDIF is delighted to cooperate with Serum Institute of India, the world's largest vaccine manufacturer," said Kirill Dmitriev, the CEO at RDIF. "This strategic partnership is a major step to substantially increase our production capabilities demonstrating a perfect example of joining forces and expertise to save lives both in India and around the world," Dmitriev added.

    4/8

    'Important to bolster our fight against the pandemic'

    Meanwhile, SII CEO Adar Poonawalla said in a statement, "We hope to make millions of doses in the coming months with trial batches starting in the month of September." "With high efficacy and a good safety profile, it is critical that the Sputnik vaccine is accessible in full measure for people across India and the world," he added.

    5/8

    SII is associated with three other vaccines

    SII is also involved in the manufacturing of Covishield (the Oxford-AstraZeneca vaccine which is the most prevalent in India) and Covovax (the Indian version of the Novavax COVID-19 vaccine). It is also carrying out trials of Codagenix in the UK.

    6/8

    Sputnik V is over 90% effective against COVID-19

    Sputnik V, an adenoviral vaccine, was found to be over 90% effective in trials. It has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Ministry of Health. The RDIF has, in the past, tied up with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech, and Morepen Laboratories for the vaccine's production.

    7/8

    'Sputnik V's commercial launch in coming weeks'

    For now, the Hyderabad-based Dr. Reddy's Laboratories has been importing limited amounts of Sputnik V vaccine doses and distributing them to hospitals across India. "We will strengthen the commercial roll-out of Sputnik V in the coming weeks," Dr. Reddy's said on Monday.

    8/8

    How is India's vaccination drive going?

    The development holds significance as several states across India, including Delhi, are currently facing a vaccine shortage. India has administered over 38 crore vaccine doses so far. Even though over 22% of Indians have received at least one vaccine shot, just around 5.5% have been fully inoculated as yet. The central government, nonetheless, plans to vaccinate all adults by the end of this year.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Serum Institute of India
    Sputnik V
    COVID-19 Vaccination

    Serum Institute of India

    Expert panel says no to Covovax's children trials in India Central Drugs Standard Control Organization (CDSCO)
    'Not received Covishield approval request,' says EU body amid concerns European Union Intellectual Property Office (EUIPO)
    Serum to begin Covovax trials on children in July COVID-19
    Efforts on to restart AstraZeneca shipments from India: WHO official World Health Organization

    Sputnik V

    Morepen Laboratories starts production of test batch of Sputnik V Coronavirus
    Two Delhi-NCR hospitals start administering Sputnik V; over 3K vaccinated Fortis Hospital
    Haryana may receive 60mn Sputnik V doses from Malta-based company Haryana
    Deck cleared for import of COVAXIN, Sputnik V into Brazil Brazil

    COVID-19 Vaccination

    Delhi out of Covishield stock, many vaccine centers shut today Delhi
    Third COVID-19 wave "imminent," says IMA, warns against laxity Health & Wellness
    Coronavirus: India reports over 42K fresh cases, 1,200+ deaths Government of India
    COVID-19 task force chief points to crowds, warns new surge India
    Next News Article

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023